Finance

Lists
Why is 600812 down 4.72%?
Dive Deeper
600812:SHA
North China Pharmaceutical Co Ltd
CN¥ 6.26
-4.72%
(-0.31) 1D
10-р сарын 16, 15:00:00 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600812...
Open
CN¥ 6.33
High
CN¥ 6.90
Low
CN¥ 6.10
Avg. vol.
61.12 сая
Volume
307.76 сая
Dividend
0.56%
Quarterly dividend
CN¥ 0.01
Ex-dividend date
2026 оны 6-р сарын 11
P/E ratio
87.26
52-wk high
CN¥ 6.90
52-wk low
CN¥ 4.11
EPS
CN¥ 0.07
Shares outstanding
1.63 тэрбум
No. of employees
10 мян
Open
CN¥ 6.33
High
CN¥ 6.90
Low
CN¥ 6.10
Avg. vol.
61.12 сая
Volume
307.76 сая
Dividend
0.56%
Quarterly dividend
CN¥ 0.01
Ex-dividend date
2026 оны 6-р сарын 11
P/E ratio
87.26
52-wk high
CN¥ 6.90
52-wk low
CN¥ 4.11
EPS
CN¥ 0.07
Shares outstanding
1.63 тэрбум
No. of employees
10 мян
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
1 цагийн өмнө
Iambic Therapeutics raises USD 150m in Nasdaq IPO
Profile
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
About North China Pharmaceutical Co Ltd
CEO-
Employees9.97 мян
Founded1992 оны 12-р сарын 20
Headquarters-
SectorPharmaceutical industry
Website-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.21 тэрбум
1.76 тэрбум
2.15 тэрбум
2.07 тэрбум
Cost of goods sold
1.59 тэрбум
1.07 тэрбум
1.53 тэрбум
1.54 тэрбум
Cost of revenue
1.59 тэрбум
1.07 тэрбум
1.53 тэрбум
1.54 тэрбум
Research and development expenses
85.19 сая
85.95 сая
95.62 сая
84.71 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
419.54 сая
414.91 сая
354.22 сая
304.68 сая
Operating expense
504.74 сая
539.54 сая
495.25 сая
396.76 сая
Total operating expenses
2.09 тэрбум
1.61 тэрбум
2.03 тэрбум
1.94 тэрбум
Operating income
116.01 сая
149.57 сая
128.11 сая
125.58 сая
Other non operating income
-299.86 мян
-2.96 сая
-10.58 сая
6.02 сая
EBT including unusual items
73.18 сая
70.19 сая
66.28 сая
57.65 сая
EBT excluding unusual items
45.54 сая
84.31 сая
61.80 сая
58.08 сая
Income tax expense
23.93 сая
24.28 сая
16.90 сая
16.15 сая
Effective tax rate
32.70%
34.59%
25.50%
28.02%
Other operating expenses
4.82 сая
29.30 сая
27.82 сая
15.57 сая
Net income
35.01 сая
24.55 сая
35.47 сая
28.37 сая
Net profit margin
1.58%
1.40%
1.65%
1.37%
Earnings per share
-
-
-
-
Interest and investment income
19.41 сая
27.71 сая
19.26 сая
22.40 сая
Interest expense
-85.85 сая
-85.06 сая
-74.99 сая
-76.52 сая
Net interest expenses
-66.43 сая
-57.35 сая
-55.73 сая
-54.13 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
313.14 сая
371.92 сая
350.45 сая
367.38 сая
Gain or loss from assets sale
-9.85 мян
-827.34 мян
-
-217.80 мян
AI content may include mistakes. Learn more
Google аппс